Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2014 Publisher: Baxter Healthcare Ltd, Caxton Way, Thetford, Norfolk, IP24 3SE, United Kingdom
Mesna Injection.
| Pharmaceutical Form |
|---|
|
Ampoules of aqueous solution for intravenous and oral administration. |
Clear, glass ampoules containing a clear, colourless, aqueous solution of mesna (sodium 2-mercapto-ethanesulphonate) 400 mg in 4 ml and 1000 mg in 10 ml.
| Active Ingredient | Description | |
|---|---|---|
| Mesna |
Mesna is an antidote, and offers the possibility of reliably preventing urotoxic side-effects associated with aggressive cancer chemotherapy using oxazaphosphorine cytostatics. |
| List of Excipients |
|---|
|
Disodium edetate |
15 clear glass ampoules containing a clear colourless sterile aqueous solution of mesna in a folded cardboard box. Ampoules contain 4 ml or 10 ml of solution.
Baxter Healthcare Ltd, Caxton Way, Thetford, Norfolk, IP24 3SE, United Kingdom
PL 00116/0395
15 December 2003
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
